AdAlta (ASX:1AD) aims to become a leader in cell therapy for cancer, providing a pathway for innovative cellular immunotherapies for solid cancers originating in Asia, and China particularly, to reach western regulated markets. Subsidiary company, AdCella, in-licenses first in class or best in class assets, establishes manufacturing and generates clinical data in Australia under a US IND at substantially lower cost than in the US. We act as a force multiplier for our Asian partners, enabling them to reach western markets at no cost but while sharing the upside with us.
AdAlta also has a portfolio of assets developed using its proprietary i-body technology available for out-licensing, including:
1. AD-214 is a first in class antifibrotic being developed for lung and kidney fibrosis. With two Phase 1 trials complete, it is ready to advance to Phase 2 trials, providing a much needed new option for patients living under a death sentence with degenerative diseases such as Idiopathic Pulmonary Fibrosis.
2. WD-34 is the first anti-body-like molecule to inhibit malaria, babesia and toxoplasma invasion of red blood cells and liver cells across all strains of these parasites, offering the potential to transform seasonal and deployed personnel malaria prophylaxis
Company Details
- Employees
- 13
- Founded
- -
- Address
- Burke Rd, Camberwell,victoria 3124,australia
- Phone
- 61394795159
- en****@****.com.au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- adalta.com.au
- HQ
- Camberwell, Victoria
Adalta Ltd Questions
Adalta Ltd's helpline number is 61394795159
Adalta Ltd's website is adalta.com.au
Adalta Ltd's LinkedIn profile is https://au.linkedin.com/company/adalta-ltd
Adalta Ltd has
13 employees.
View email and phone details for 13
employees at Adalta Ltd.
Adalta Ltd's industry is
Biotechnology Research
Adalta Ltd's top competitors are
Dimerix Limited,
Carina Biotech,
Gertrude Biomedical,
Populus Bio Sarl,
Imunexus Therapeutics Limited,
Vivazome Therapeutics,
Cell Therapies Pty Ltd,
Arovella Therapeutics Asx: Ala,
Acrux,
360biolabs, A Bioagilytix Company.
Adalta Ltd's support email address is enquiries@adalta.com.au
Adalta Ltd's categories are Biotechnology Research
Adalta Ltd's founding year is 2007
